Warren Eric
SEC insider (Form 3/4/5 filer). CIK 0001916048. Chief Commercial Officer at Mineralys Therapeutics, Inc. (MLYS) and 1 other issuer. 17 reported Form 4/5 transactions since Sep 2024; latest on Sep 21, 2026. Located in RADNOR, PA.
Companies Warren Eric has filed insider reports for
- Mineralys Therapeutics, Inc. (MLYS): Officer, Chief Commercial Officer
- Esperion Therapeutics, Inc. (ESPR): Officer, Chief Commercial Officer
Warren Eric
CIK: 0001916048
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Sep 21, 2026MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect7.4K shares at avg. $13.24$98K - Sep 21, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect7.4K shares at avg. $28.12$209K - Aug 21, 2026MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect7.4K shares at avg. $13.24$98K - Aug 21, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect7.4K shares at avg. $25.98$193K - Jul 21, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect7.4K shares at avg. $26.87$200K - Jul 21, 2026MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect7.4K shares at avg. $13.24$98K - Jun 26, 2026MLYS
Mineralys Therapeutics, Inc.
ExerciseDirect104.1K shares at avg. $13.24$1.4M - Jun 26, 2026MLYS
Mineralys Therapeutics, Inc.
SaleDirect104.1K shares at avg. $25.90$2.7M - Apr 17, 2025ESPR
Esperion Therapeutics, Inc.
SaleDirect108 shares at avg. $0.98$105.624 - Mar 18, 2025ESPR
Esperion Therapeutics, Inc.
SaleDirect2.4K shares at avg. $1.49$4K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 21, 2026 |  MLYS Mineralys Therapeutics, Inc. | Exercise | 7,438 | $13.24 | $98,479 | Direct |
| Sep 21, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 7,438 | $28.12 | $209,136 | Direct |
| Aug 21, 2026 | MLYS Mineralys Therapeutics, Inc. | Exercise | 7,437 | $13.24 | $98,466 | Direct |
| Aug 21, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 7,437 | $25.98 | $193,189 | Direct |
| Jul 21, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 7,438 | $26.87 | $199,885 | Direct |
| Jul 21, 2026 | MLYS Mineralys Therapeutics, Inc. | Exercise | 7,438 | $13.24 | $98,479 | Direct |
| Jun 26, 2026 | MLYS Mineralys Therapeutics, Inc. | Exercise | 104,124 | $13.24 | $1,378,602 | Direct |
| Jun 26, 2026 | MLYS Mineralys Therapeutics, Inc. | Sale | 104,124 | $25.90 | $2,696,322 | Direct |
| Apr 17, 2025 |  ESPR Esperion Therapeutics, Inc. | Sale | 108 | $0.98 | $106 | Direct |
| Mar 18, 2025 | ESPR Esperion Therapeutics, Inc. | Sale | 2,433 | $1.49 | $3,618 | Direct |
1-10 of 17 transactions